Arnell Kai, Enblad Per, Wester Tomas, Sjölin Jan
Department of Pediatric Surgery, University Hospital, Uppsala, Sweden.
J Neurosurg. 2007 Sep;107(3 Suppl):213-9. doi: 10.3171/PED-07/09/213.
There are no randomized studies comparing the efficacy of different antibiotic regimens for the treatment of cerebrospinal fluid (CSF) shunt infections, and in the studies that have been reported, efficacy data are limited. The aim of this study was therefore to report the authors' experience using a specific protocol for the management of shunt infections in children. Standard treatment included a two-stage procedure involving externalization of the ventricular catheter in combination with intraventricular and systemic administration of antibiotic medication followed by shunt replacement. Intraventricular treatment consisted of daily instillations of vancomycin or gentamicin with trough concentrations held at high levels of 7 to 17 mg/L for both antibiotic agents.
During a 13-year study period, the authors treated 34 consecutive intraventricular shunt infections in 30 children. Infections with coagulase-negative staphylococci predominated, and Gram-negative bacterial infection occurred in five children. Ten of the children were initially treated with intravenous antibiotic therapy for at least 3 days, but this treatment did not sterilize the CSF. After externalization of the ventricular catheter, high-dose intraventricular treatment was given for a median of 8 days (range 3-17 days) before shunt replacement.
The CSF was found to be sterile (cultures were negative for bacteria) in one of three, seven of eight, 20 of 20, and six of six cases after 1, 2, 3, and more than 3 days' treatment, respectively. In no case was any subsequent culture positive after a negative result had been obtained. Clinical symptoms resolved in parallel with the sterilization of the CSF. There were no relapses or deaths during the 6-month follow-up period, and there have been none as of April 2007.
Despite the ventricular catheter being left in place and the short duration of therapy, the treatment regimen described by the authors resulted in quick sterilization of the CSF, a low relapse rate, and survival of all patients in this series.
尚无随机研究比较不同抗生素方案治疗脑脊液(CSF)分流感染的疗效,且在已报道的研究中,疗效数据有限。因此,本研究的目的是报告作者使用特定方案管理儿童分流感染的经验。标准治疗包括两阶段程序,即脑室导管外置化,同时联合脑室内及全身应用抗生素药物,随后进行分流器置换。脑室内治疗包括每日滴注万古霉素或庆大霉素,两种抗生素的谷浓度均维持在7至17mg/L的高水平。
在为期13年的研究期间,作者连续治疗了30例儿童的34例脑室内分流感染。以凝固酶阴性葡萄球菌感染为主,5例儿童发生革兰阴性菌感染。10例儿童最初接受了至少3天的静脉抗生素治疗,但该治疗未能使脑脊液无菌。脑室导管外置化后,在分流器置换前给予高剂量脑室内治疗,中位时间为8天(范围3 - 17天)。
分别在治疗1天、2天、3天和超过3天后,三分之一、八分之七、二十分之二十和六分之六的病例脑脊液无菌(细菌培养阴性)。在获得阴性结果后,无一例后续培养呈阳性。临床症状随脑脊液无菌化而缓解。在6个月的随访期内无复发或死亡病例,截至2007年4月也无此类情况。
尽管脑室导管留置原位且治疗时间短,但作者描述的治疗方案使脑脊液迅速无菌化,复发率低,本系列所有患者均存活。